Home/Pipeline/Syndromic Molecular Panel Expansion

Syndromic Molecular Panel Expansion

Various Infectious Disease Syndromes (STI, GI, Respiratory, etc.)

Commercial & DevelopmentActive

Key Facts

Indication
Various Infectious Disease Syndromes (STI, GI, Respiratory, etc.)
Phase
Commercial & Development
Status
Active
Company

About Adaltis

Adaltis is a commercial-stage, privately-held Italian IVD company with a 25+ year history. It has built a diversified portfolio spanning molecular diagnostics instruments and test kits, automated MicroELISA analyzers, and associated reagents. The company leverages both open-platform instruments and proprietary test panels, serving a global market through a direct and partner sales model. Its recent focus includes expanding its syndromic molecular panels and fully integrated 'All-in-One' MDx platforms to capitalize on the growing demand for automated, high-throughput infectious disease testing.

View full company profile